Common Stock, Shares, Issued of BridgeBio Oncology Therapeutics, Inc. from 01 Feb 2024 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary: BridgeBio Oncology Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 01 Feb 2024 to 31 Dec 2025.
BridgeBio Oncology Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 79,991,768, a 281412% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Shares, Issued, Quarterly (shares)

Common Stock, Shares, Issued, YoY Quarterly Change (%)

BridgeBio Oncology Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	79,991,768	+79,963,353	+281412%	31 Dec 2025	10-K	05 Mar 2026	2025	FY
Q3 2025	79,196,710			30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q4 2024	28,415	-4,194,085	-99%	31 Dec 2024	10-K	05 Mar 2026	2025	FY
Q4 2023	4,222,500			01 Feb 2024	10-Q	15 May 2024	2024	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.